<!-- <div class="hidden-reset-btn"></div> -->
<div class="develop-home view">
<!-- 	<div class="incyte-ref"><h6>INC-1200a</h6></div> -->	
	<div class="home-btn">
		<span>
			<img src="images/incyte-home-btn.png" alt="HOME" title="HOME">
		<span>
	</div>
	 <div class="goback-btn nav-button develop loads-page" data-pagelink="develop"">
		<span>
			<img src="images/ashe-incyte-back-btn.png" alt="HOME" title="HOME">
		</span>
	</div>

	<h1 class="text-center">SELECT a study below</h1>

 	<div class="container absolute-center">
	 	<div class="col-xs-12 text-center">
			<h2 class="well well-lg nav-button study-home-a loads-page" data-pagelink="study-home-a">
				Phase 2: A Study of INCB050465 (PI3K&delta; inhibitor) in Combination 
				<br class="hide991">
				with Ruxolitinib in Subjects with Myelofibrosis
			</h2>
			<hr><p>OR</p><hr>
			<h2 class="well well-lg nav-button study-home-b loads-page" data-pagelink="study-home-b">
				Phase 1/2: INCB039110 (JAK1 inhibitor) in Combination with
				<br class="hide991">
				 Ibrutinib in Subjects with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
			</h2>
		</div>
	</div>
	<div class="liaison-box text-center"><h6>To learn if any of your patients might be eligible for participation in these studies or to learn more about becoming an investigator, please speak with one of our Medical Science Liaisons.</h6></div>

</div>

<!-- 		<div class="footnotes2">INC-1186a 08/16</div>
 --><!-- VIDEOS -->
<!-- <div id="video_pop"></div>
 -->
<!-- NAVIGATION -->
<!-- <aside class="side-nav"></aside>
 -->

<!-- <script>
  $(document).ready(function() {  
  		 $("#carousel-home").swiperight(function() {  
    		  $(this).carousel('prev');  
	    		});  
		   $("#carousel-home").swipeleft(function() {  
		      $(this).carousel('next');  
	   });  
	});  
</script> -->